Details of the Drug
General Information of Drug (ID: DMTBAUG)
Drug Name |
2,2-Diphenyl-ethylamine
|
||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms |
2,2-Diphenylethylamine; 3963-62-0; 2,2-Diphenylethanamine; 2,2-Diphenyl-ethylamine; 1-Amino-2,2-diphenylethane; 2,2-Diphenylethan-1-Amine; CHEMBL10780; 2,2-Diphenylethylamine, 96%; RXMTUVIKZRXSSM-UHFFFAOYSA-N; NSC27209; EINECS 223-565-7; PubChem7986; ACMC-1CSWZ; 2,2-diphenylethyl-amine; 2,2- diphenylethylamine; AC1L2TCM; beta-phenylbenzeneethanamine; 2,2-diphenyl-ethyl-amine; 2,2-diphenyl ethyl amine; 2,2-di(phenyl)ethanamine; 2,2-Diphenylethanamine #; 2,2-bis-phenyl-ethylamine; AC1Q53LU; Benzeneethanamine, b-phenyl-
|
||||||||||||||||||||||
Indication |
|
||||||||||||||||||||||
Drug Type |
Small molecular drug
|
||||||||||||||||||||||
Structure | |||||||||||||||||||||||
3D MOL | 2D MOL | ||||||||||||||||||||||
#Ro5 Violations (Lipinski): 0 | Molecular Weight (mw) | 197.27 | |||||||||||||||||||||
Logarithm of the Partition Coefficient (xlogp) | 2.1 | ||||||||||||||||||||||
Rotatable Bond Count (rotbonds) | 3 | ||||||||||||||||||||||
Hydrogen Bond Donor Count (hbonddonor) | 1 | ||||||||||||||||||||||
Hydrogen Bond Acceptor Count (hbondacc) | 1 | ||||||||||||||||||||||
Chemical Identifiers |
|
||||||||||||||||||||||
Cross-matching ID | |||||||||||||||||||||||
Molecular Interaction Atlas of This Drug
Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||
Molecular Expression Atlas of This Drug
The Studied Disease | Discovery agent | |||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ICD Disease Classification | N.A. | |||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
Molecular Expression Atlas (MEA) | ||||||||||||||||||||||||||||||